Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan

Journal of Infection

Volumn 63, Issue 4, 2011, Pages 281-287

  Toyokawa, Takao ^a,b   Sunagawa, Tomimasa ^a   Yahata, Yuichiro ^a   Ohyama, Takaaki ^a   Kodama, Tomoko ^c   Satoh, Hiroshi ^a   Ueno Yamamoto, Kumi ^a   Arai, Satoru ^a   Araki, Kazuko ^a   Odaira, Fumito ^a   Tsuchihashi, Yuuki ^a   Takahashi, Hideaki ^a   Tanaka Taya, Keiko ^a   Okabe, Nobuhiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Health personnel; Influenza; Outbreak; Seroepidemiologic studies

Indexed keywords

ANTIVIRUS AGENT; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD ANALYSIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPIDEMIC; FEMALE; FEVER; GENERAL HOSPITAL; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION RISK; JAPAN; LABORATORY PERSONNEL; MAJOR CLINICAL STUDY; MALE; NURSE; OCCUPATIONAL EXPOSURE; PHARMACIST; PHYSICIAN; PROTECTIVE EQUIPMENT; QUESTIONNAIRE; RADIOLOGICAL TECHNOLOGIST; SEROEPIDEMIOLOGY; SEROPREVALENCE; SURGICAL MASK;

ADULT; AGED; ANTIBODIES, VIRAL; ASYMPTOMATIC DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HEMAGGLUTINATION INHIBITION TESTS; HOSPITALS, GENERAL; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; PANDEMICS; PROTECTIVE CLOTHING; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES;

EID: 80052952657     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.001     Document Type: Article

References (19)

1. Tang J., Tambyah P., Wilder-Smith A., Puong K., Shaw R., Barr I., et al. Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore. Emerg Infect Dis 2010 May, 16(5):874-876.
2. Ross T., Zimmer S., Burke D., Crevar C., Carter D., Stark J., et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr 2010, RRN1148.
3. Chen H., Wang Y., Liu W., Zhang J., Dong B., Fan X., et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009 Nov, 15(11):1849-1850.
4. Hancock K., Veguilla V., Lu X., Zhong W., Butler E., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009 Nov, 361(20):1945-1952.
5. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010 Mar, 375(9720):1100-1108.
6. Allwinn R., Geiler J., Berger A., Cinatl J., Doerr H. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?. Med Microbiol Immunol 2010 May, 199(2):117-121.
7. Ikonen N., Strengell M., Kinnunen L., Osterlund P., Pirhonen J., Broman M., et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010 Feb, 15(5).
8. Chen M., Lee V., Lim W., Barr I., Lin R., Koh G., et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010 Apr, 303(14):1383-1391.
9. Bandaranayake D., Huang S., Bissielo A., Wood T. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand [cited 2010 1st Nov.] Available from. http://www.moh.govt.nz/moh.nsf/pagesmh/10124/$File/seroprevalence-flu-2009.pdf.
10. Chan Y., Lee C., Hwang S., Fung C., Wang F., Yen D., et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc 2010 Feb, 73(2):62-66.
11. Takahashi H, Tsuchihashi Y, Odaira F, Toyokawa T, Sunagawa T, Taniguchi K, et al. Pandemic influenza A(H1N1)pdm outbreak - Hyogo Prefecture, Japan, 2009. The 5th TEPHINET Southeast Asia and Western Pacific Bi-regional Scientific Conference; Korea 3rd-6th Nov. 2009. [poster].
12. Shiino T., Okabe N., Yasui Y., Sunagawa T., Ujike M., Obuchi M., et al. Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 2010, 5(6):e11057. 10.1371/journal.pone.0011057.
13. Kendal A., Pereira M., Skehel J. Concepts and procedures for laboratory-based influenza surveillance 1982, US Department of Health and Human Services, CDC, Atlanta, GA.
14. Okabe N., Tanaka-Taya K., Satoh H. Seroepidemiological survey for A/California 07/2009 pdm (pandemic A/H1N1 pdm) in Japan. Submitted reference data from Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan to governmental skull session on pandemic (H1N1) 2009 vaccine 24th Sep 2009, (in Japanese). [cited 2010 1st November]; Available from. http://www.mhlw.go.jp/kinkyu/kenkou/influenza/dl/infu090924-02.pdf.
15. CDC, Prevention Novel influenza A (H1N1) virus infections among health-care personnel - United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009 Jun, 58(23):641-645.
16. Elder A., O'Donnell B., McCruden E., Symington I., Carman W. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 1996 Nov, 313(7067):1241-1242.
17. Wilde J., McMillan J., Serwint J., Butta J., O'Riordan M., Steinhoff M. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999 Mar, 281(10):908-913.
18. Carrat F., Vergu E., Ferguson N., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr, 167(7):775-785.
19. Welliver R., Monto A., Carewicz O., Schatteman E., Hassman M., Hedrick J., et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001 Feb, 285(6):748-754.